Skip to main content
. 2017 Feb 6;24(1):370–379. doi: 10.1080/10717544.2016.1256000

Table 3. Ocular tissue DFS concentration (μg/g of tissue) obtained from various topical formulations of DFS.

Formulations (#) Time (h) post instillation Group # Cornea AH IC RC Sclera
0.1%w/v DFS solution (#1) 4 1 NA 0.18 ± 0.06 0.93 ± 0.4 NA NA
1.6%w/v DFSfree+DFS:IR(1:1)(3 + 1) suspension (#2) 8 2 1.3 ± 1.0 0.18 ± 0.07 0.43 ± 0.19 ND 8.4 ± 1.7
20%w/w DFSfree Film (#3) 4 3 NA 2.6 ± 0.2* 2.7 ± 1.1b NA NA
  8 4 7.5 ± 3.4 0.7 ± 0.06b 0.78 ± 0.35c ND 14.6 ± 4.8
20%w/w DFSfree+DFS:IR(1:1)(3 + 1) Film (#4) 4 5 NA 0.9 ± 0.2* 1.02 ± 0.05 NA NA
  8 6 2.3 ± 1.4 0.36 ± 0.06a 0.66 ± 0.15c 0.09 ± 0.02 7.02 ± 4.03

AH - Aqueous humor, IC - Iris ciliary bodies, RC - Retina-choroid. NA - not analyzed, ND - below detection limit. Statistical significance was calculated using Tukey HSD (IBM SPSS 23). *Significantly different from all groups, aSignificantly different from group #5, bSignificantly different from all groups except group #5, cSignificantly different from group #3.